Medical Cannabis After Rescheduling: Defending Workers' Comp Reimbursement Claims and Building Intoxication Denials That Hold at Hearing

Live · 2 CLE credits · November 23, 2026, 12:00 PM ET

Marijuana's move from Schedule One to Schedule Three has reopened workers' comp fights over medical cannabis reimbursement and intoxication denials. Assert eight reimbursement defenses, demand proof the product and expenses qualify, read urine and blood THC results correctly, and depose the claimant's toxicologist.

Rescheduling Didn’t Make Medical Cannabis Reimbursable or THC Tests Proof of Intoxication

Marijuana has moved from Schedule One to Schedule Three. Claimants now argue the Attorney General's Order ends the preemption fight over workers' comp reimbursement of medical cannabis. It does not. Schedule Three substances remain controlled substances, and state programs certify cannabis rather than prescribe it. The Order addresses FDA-approved products and qualifying state medical marijuana licenses, not every product sold in a state.

Concede preemption and Bierbach and Musta are off the table. Accept a state certification as a federal prescription and a defense is gone. Reimburse a purchase made before April 23, 2026, and you have granted a retroactive entitlement the Order never created. Urine THC-COOH and blood Delta-9 results answer different questions. Delta-8 interference changes what a positive means. A test the lab cannot defend will not carry the burden of proof in California, Florida, or Georgia.

You leave with an eight-defense framework for reimbursement claims and the proof requests to serve on every one: manufacturer, licensed-program purchase, THC composition and dosage, purchase date, itemized receipts. You also get Florida, Alabama, and Ohio's non-coverage clauses and a case-report method for reading urine, blood, and Delta-8 results, requesting lab records, and deposing the claimant's toxicologist.

Key topics

Agenda

Faculty

State accreditation